Table 1.
Clinical, tumor stages and histological features of NSCLC affected patients enrolled for the study (n = 59).
| Characteristics | TOTAL (n = 59) | ADC (n = 34) | SqCC (n = 25) |
|---|---|---|---|
| Age at Diagnosis (mean yy ± SD) | 67.7 ± 8.4 | 67.5 ± 10.2 | 68.0 ± 5.2 |
| Gender (n, %) | |||
| Male | 50 (84.8) | 25 (73.5) | 25 (100.0) |
| Female | 9 (15.2) | 9 (26.5) | 0 (0.0) |
| Smoking status (n, %) | |||
| Smoker | 28 (47.5) | 13 (38.2) | 15 (60.0) |
| Never smoker | 6 (10.1%) | 6 (17.7) | 0 (0.0) |
| Former smoker | 25 (42.4%) | 15 (44.1) | 10 (40.0) |
| Disease Stage | |||
| IA/B | 28 (47.5) | 18 (52.9) | 10 (40.0) |
| IIA/B | 14 (23.7) | 6 (17.7) | 8 (32.0) |
| IIIA/B | 11 (18.6) | 4 (11.7) | 7 (28.0) |
| IV | 6 (10.2) | 6 (17.7) | 0 (0.0) |
| pT § (n, %) | |||
| T1 | 20 (33.9) | 14 (41.2) | 6 (24.0) |
| T2 | 27 (45.7) | 14 (41.2) | 13 (52.0) |
| T3 | 6 (10.2) | 4 (11.7) | 2 (8.0) |
| T4 | 6 (10.2) | 2 (5.9) | 4 (16.0) |
| pN † (n, %) | |||
| N0 | 42 (71.2) | 27 (79.4) | 15 (60.0) |
| N1 | 10 (17.0) | 3 (8.8) | 7 (28.0) |
| N2 | 7 (11.8) | 4 (11.8) | 3 (12.0) |
| pM (n, %) | |||
| M0 | 54 (91.5) | 29 (85.3) | 25 (100.0) |
| M1 | 5 (8.5) | 5 (14.7) | 0 (0.0) |
ADC, adenocarcinoma; SqCC, squamous cell carcinoma; yy, years; SD, standard deviation. § pT, pathological Tumor; † pN, pathological Node.